Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8‐week, double‐blind, multicenter, randomized controlled study
Author:
Affiliation:
1. Leonard M. Miller Professor of Psychiatry and Behavioral Sciences University of Miami Miller School of Medicine Miami Florida
2. Medical Affairs Sumitomo Dainippon Pharma Co., Ltd Tokyo Japan
3. Institute of CNS Pharmacology Kanagawa Japan
Funder
Dainippon Sumitomo Pharma
Publisher
Wiley
Subject
Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12057
Reference29 articles.
1. Cognition in Schizophrenia: Impairments, Determinants, and Functional Importance
2. What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis
3. Early interventions in risk groups for schizophrenia: what are we waiting for?
4. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
5. Investigating trajectories of social recovery in individuals with first-episode psychosis: A latent class growth analysis
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review;Brain Sciences;2024-04-03
2. Novel therapies for nausea and vomiting in advanced illness and supportive cancer care;Palliative Care and Social Practice;2024-01
3. Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials;BMC Psychiatry;2023-10-11
4. Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance;BMC Psychiatry;2023-02-21
5. Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance;Frontiers in Psychiatry;2022-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3